Professor Erik Fosse from The Intervention Centre at the Division of Diagnostics and Intervention, OUS, is awarded the University of Oslo Innovation prize for his creations within the fields of medicine and health service.
Fosse will receive the prize at a seremony taking place during the annual party for the University of Oslo September 2nd.
Published in major journals, first or last author from Oslo University Hospital.
Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy
Ann Oncol, 29 Suppl 5, v109
An emerging focus on lipids in extracellular vesicles
Adv Drug Deliv Rev (in press)
Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial
Lancet, 395 (10228), 951-961